Skip to main content
Clinical Trials/JPRN-UMIN000006343
JPRN-UMIN000006343
Completed
未知

Assessment of Atrial Late Potentials in Patients with Hypertention to Investigate the Preventive Effect of Eplerenone on Atrial Fibrillation. - Assessment of Atrial Late Potentials in Patients with Hypertention to Investigate the Preventive Effect of Eplerenone on Atrial Fibrillation.

Osaka General Medical Center0 sites40 target enrollmentOctober 1, 2011
ConditionsHypertention

Overview

Phase
未知
Intervention
Not specified
Conditions
Hypertention
Sponsor
Osaka General Medical Center
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2011
End Date
September 1, 2013
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients who have a contraindication to Selara TAB administration. 2\. Patients who have a contraindication to Norvasc TAB administration . 3\. Patients with liver dysfunction (AST or ALT values of \>\=100IU). 4\. Patients who are judged by the investigator to be not eligible for enrollment in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials